The Global Carrier Screening Market was valued at USD 1,245.4 Million in 2023 and is expected to reach USD 3260 Million by 2030, Growing at a CAGR of 12.6% from 2023 to 2030.

The Global Carrier Screening Market is expected to experience significant growth in the coming years due to increasing awareness about genetic disorders, advances in genetic testing technologies, and increasing government initiatives to promote carrier screening. Carrier screening is a type of genetic testing that helps identify individuals who are carriers of certain genetic conditions or diseases, even if they do not have symptoms themselves. Carrier screening is typically offered to individuals who have a family history of a genetic condition or are planning to have children.

Impact of Covid-19 Pandemic on Carrier Screening Market

The COVID-19 pandemic has had a significant impact on the carrier screening market. The demand for carrier screening has increased as individuals have become more concerned about the potential for genetic conditions being passed on to their children. Additionally, the pandemic has disrupted supply chains and disrupted the availability of carrier screening tests, leading to delays in testing and reduced capacity for testing.

Global Carrier Screening Market Segmentation

By Type

• Targeted Carrier Screening
• Expanded Carrier Screening
• Customized Panel Testing
• Predesigned Panel Testing

By Medical Condition

• Haematological Conditions
• Pulmonary Conditions
• Neurological Conditions
• Others

By Services and Products

• Products
• Services

Key Players of Global Carrier Screening Market

• Myriad Genetics
• Cepheid
• Illumina
• Thermo Fisher Scientific
• F.Hoffmann-La Roche
• Laboratory Corporation of America Holdings
• Otogenetics
• MedGenome
• GeneTech
• Centogene N.V.

By Type

Targeted Carrier Screening: 

This type of carrier screening tests for specific genetic conditions that are known to be prevalent in a particular population or that are of particular concern to the individual being tested.

Expanded Carrier Screening:

This type of carrier screening tests for a wider range of genetic conditions, including both common and rare conditions.

Customized Panel Testing:

This type of carrier screening involves testing for a specific set of genetic conditions that are selected by the individual being tested or their healthcare provider.

Predesigned Panel Testing:

This type of carrier screening involves testing for a predetermined set of genetic conditions that are commonly included in carrier screening panels.

The different types of carrier screening tests available include targeted carrier screening, expanded carrier screening, customized panel testing, and predesigned panel testing. Each of these types of carrier screening tests has its own advantages and disadvantages, and the appropriate type of testing will depend on the specific needs and circumstances of the individual being tested.

By Medical Condition

Haematological Conditions:

These are conditions that affect the blood and blood-forming tissues, such as sickle cell anaemia and thalassemia.

Pulmonary Conditions:

These are conditions that affect the respiratory system, such as cystic fibrosis.

Neurological Conditions:

These are conditions that affect the nervous system, such as spinal muscular atrophy.

Carrier screening is a type of genetic testing that is used to determine whether an individual is a carrier of a genetic condition. Carrier screening is often offered to people who are planning to have children or who have a family history of a genetic condition. The carrier screening market is driven by the increasing prevalence of genetic conditions and the increasing awareness of the importance of carrier screening.

By Services and Products

Products:

These include the various types of carrier screening tests that are available, such as blood tests, saliva tests, and cheek swab tests.

Services:

These include the various services that are provided in conjunction with carrier screening, such as genetic counselling and interpretation of test results.

The carrier screening market can be segmented by services and products. The services segment includes pre-conception carrier screening, prenatal carrier screening, and new born screening. The products segment includes kits and reagents, software, and services.

Recent Development on Carrier Screening Market

There have been several recent developments in the carrier screening market, including the introduction of new carrier screening tests, the expansion of carrier screening into developing countries, and the increasing use of non-invasive prenatal testing (NIPT) as a form of carrier screening.

Technology Type Insights on Carrier Screening Market

Carrier screening tests use a variety of technologies, including DNA sequencing, microarray analysis, and PCR (polymerase chain reaction). Each of these technologies has its own advantages and disadvantages, and the appropriate technology will depend on the specific needs and circumstances of the individual being tested.

Regional Insights

The Carrier Screening Market is highly geographically segmented, with different regions having different market dynamics. The market in North America is the largest due to the high adoption of carrier screening in the region. However, the market in Asia Pacific is expected to grow at the highest CAGR due to the increasing awareness of carrier screening and the growing healthcare infrastructure in the region.

North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific

• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA